1. Bannon, M. J., Grace, A. A., Bunney, B. S., Roth, R. H.: Evidence for an irreversible interaction of bromocriptine with central dopamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol.312, 37?41 (1980).
2. Beumont, P., Bruwer, J., Pimstone, B., Vinik, A., Utian, W.; Brom-ergocryptine in the treatment of Phenothiazine-induced Galactorrhoea.126, 285?288 (1975).
3. Burt, D. R., Creese, I., Snyder, S. H.: Properties of [3H]-haloperidol and [3H]-dopamine binding associated with dopamine receptors in calf brain membranes. Molec. Pharmacol.12, 800?812 (1976).
4. Calne, D. B.: Role of ergot derivatives in the treatment of parkinsonism. Fed. Proc.37, 2207?2209 (1978).
5. Clark, B. J., Fluckiger, E., Loew, D. M., Vigouret, J. -M.: How does bromocriptine work? Triangle17, 21?31 (1978).